Jyong Biotech Statistics
Total Valuation
Jyong Biotech has a market cap or net worth of $240.70 million. The enterprise value is $263.11 million.
| Market Cap | 240.70M |
| Enterprise Value | 263.11M |
Important Dates
The next estimated earnings date is Wednesday, February 25, 2026, before market open.
| Earnings Date | Feb 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Jyong Biotech has 76.90 million shares outstanding. The number of shares has increased by 0.13% in one year.
| Current Share Class | 76.90M |
| Shares Outstanding | 76.90M |
| Shares Change (YoY) | +0.13% |
| Shares Change (QoQ) | +0.27% |
| Owned by Insiders (%) | 61.49% |
| Owned by Institutions (%) | 0.49% |
| Float | 29.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.62
| Current Ratio | 0.62 |
| Quick Ratio | 0.62 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.91 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -5.44% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -18.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 18.20 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 24.10 |
| Average Volume (20 Days) | 1,832,683 |
Short Selling Information
The latest short interest is 649,057, so 0.84% of the outstanding shares have been sold short.
| Short Interest | 649,057 |
| Short Previous Month | 252,374 |
| Short % of Shares Out | 0.84% |
| Short % of Float | 2.19% |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -1.92M |
| Pretax Income | -2.95M |
| Net Income | -2.95M |
| EBITDA | -1.80M |
| EBIT | -1.92M |
| Earnings Per Share (EPS) | -$0.04 |
Balance Sheet
The company has $17.01 million in cash and $35.19 million in debt, with a net cash position of -$18.19 million or -$0.24 per share.
| Cash & Cash Equivalents | 17.01M |
| Total Debt | 35.19M |
| Net Cash | -18.19M |
| Net Cash Per Share | -$0.24 |
| Equity (Book Value) | -22.47M |
| Book Value Per Share | -0.31 |
| Working Capital | -10.39M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Jyong Biotech does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.13% |
| Shareholder Yield | -0.13% |
| Earnings Yield | -1.20% |
| FCF Yield | n/a |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |